The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2− early breast cancer
出版年份 2014 全文链接
标题
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2− early breast cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 111, Issue 5, Pages 837-842
出版商
Springer Nature
发表日期
2014-07-09
DOI
10.1038/bjc.2014.339
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue
- (2014) Anna Sapino et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement†
- (2013) H. A. Azim et al. ANNALS OF ONCOLOGY
- Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses
- (2013) Roman Rouzier et al. BREAST CANCER RESEARCH AND TREATMENT
- Prospective cost-effectiveness analysis of genomic profiling in breast cancer
- (2013) V.P. Retèl et al. EUROPEAN JOURNAL OF CANCER
- A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
- (2013) C.A. Drukker et al. INTERNATIONAL JOURNAL OF CANCER
- Cost effectiveness of gene expression profiling for early stage breast cancer
- (2012) Mo Yang et al. CANCER
- Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group
- (2012) Peter C. Dubsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer
- (2011) Z. Bago-Horvath et al. CLINICAL CANCER RESEARCH
- The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase
- (2011) Emiel Rutgers et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer
- (2010) Valesca P. Retèl et al. EUROPEAN JOURNAL OF CANCER
- The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
- (2009) S. Mook et al. ANNALS OF ONCOLOGY
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays
- (2009) Kathy S. Albain et al. BREAST
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validation of 70-gene prognosis signature in node-negative breast cancer
- (2008) J. M. Bueno-de-Mesquita et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started